GWLL — Goldenwell Biotech Cashflow Statement
0.000.00%
- $19.80m
- $19.78m
- $0.00m
Annual cashflow statement for Goldenwell Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.002 | -0.006 | -0.117 | -0.985 | -0.117 |
Changes in Working Capital | 0 | 0 | -0.088 | -0.087 | 0.002 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.002 | -0.006 | -0.205 | -1.07 | -0.115 |
Financing Cash Flow Items | -0.008 | — | 0.078 | — | -0.024 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.249 | 0.008 | 0.17 | 0.905 | 0.122 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.247 | 0.002 | -0.035 | -0.168 | 0.007 |